Wellable Weekly
In this guest episode, Nick sits down with Al Lewis, founder of Quizzify and the Validation Institute, to challenge long-held assumptions about workplace wellness. From his dramatic reversal on health screenings to a deep dive into GLP-1 education strategies, Al shares candid insights on what works and what does not in employee health. The conversation explores how a new, low-cost screening technology could reshape population health strategies, why most wellness ROI claims fall short, and how employers can better manage the surge in demand for weight loss drugs. Key Takeaways * Al Lewis has reversed his stance on biometric screenings after investing in a new, non-invasive technology that delivers similar insights at a much lower cost and with greater accessibility * Traditional screenings often fail due to high costs, administrative burden, and false positives, making them inefficient at scale * Many wellness ROI claims should be viewed critically, as they often rely on self-reported outcomes and selective data that do not accurately reflect true behavior change or cost savings * GLP-1 drugs are growing in popularity, but high dropout rates highlight the need for better education and expectation setting * Educational content can help employers guide employees through GLP-1 decisions and improve long-term success
28 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de Wellable Weekly!